Patent · US Active

Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies

US8916598B2 · kind B2 · utility

0Cited by
37References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 11, 2011
Grant dateDec 23, 2014
Priority date
Expiry dateNov 10, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D249/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Dihydroxyaryl compounds and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.